Impact of n-3 docosapentaenoic acid (DPA) supplementation on n-3 fatty acid composition of tissues in rats

Abstract : Objectives and study The role of Polyunsaturated Fatty Acids (PUFA) n-3 on lipid metabolism is well known. However, most research focuses on docosahexaenoic acid (DHA, C22:6 n-3) and eicosapentaenoic acid (EPA, C20:5 n-3). Few studies concern docosapentaenoic acid n-3 (DPA n-3, C22:5 n-3), which is not commercially available in sufficient amount for in vivo studies. This fatty acid is an intermediate between EPA and DHA in the n-3 PUFA conversion pathway from α-linolenic acid (ALA, C18:3 n-3). It could be of interest both for DPA ability to be converted to EPA or DHA, mostly in the liver; and for its potential specific physiological effects. To our knowledge, no studies have been able to observe globally the specific enrichment of this fatty acid in the tissues when it was supplemented in vivo. The objective of this study is therefore to examine the effect of DPA supplementation at a physiological dose on the PUFA composition of the main tissues in rats in order to guide future studies towards the search for physiological effects. Methods DPA was purified by preparative liquid chromatography. Two groups of Sprague Dawley male rats (n= 8 / group) were fed for 3 weeks from weaning with a 10% weight lipid diet supplemented or not with 0.5% DPA of total fatty acids (TFA) and containing ALA (2.3% of TFA, ratio n-6/n-3= 5). The TFA composition of 20 tissues was investigated by gas chromatography coupled to a mass spectrometer. The two groups were compared by Student's t-test (p< 0.05). Results When supplemented, the proportion of DPA is significantly increased in the heart (x2.1), lung (x1.8), spleen (x1.6), bone marrow (x1.5) and kidney (X1.3). Its proportion tends to increase in the red blood cells (x1.4) and the pancreas (x1.2) but remains stable in the liver, plasma, brain and retina that are known to be impacted with diets supplemented with EPA or with DHA. DHA status was significantly increased in the spleen (x1.2), lung (x1.2) and tends to increase in the bone marrow (x1.6). DPA supplementation would therefore increase the conversion to DHA. The proportions of EPA were significantly increased in the liver (x2.0), plasma (x2.0), spleen (x1.5), lung (x1.3) and bone marrow (x1.1). This would confirm direct or indirect retroconversion through DHA from DPA to EPA. Concerning the n-6 series PUFAs in competition with the enzymes of the n-3 conversion pathway, the proportions of DPA n-6 (C22:5 n-6) and arachidonic acid (C20:4 n- 6) decreased in some tissues specifically (red blood cells, heart, kidney, spleen, lung). Conclusion DPA supplementation at 0.5% of TFA results in enrichment of n-3 PUFA and depletion of n-6 PUFAs targeted in some tissues. This suggests a potential and specific action of this fatty acid. Future studies are now scheduled to determine the potential physiological effects of DPA in these organs as compared to DHA and EPA.
Complete list of metadatas
Contributor : Gaetan Drouin <>
Submitted on : Friday, October 5, 2018 - 2:24:01 PM
Last modification on : Thursday, October 11, 2018 - 1:12:29 AM
Long-term archiving on : Sunday, January 6, 2019 - 4:24:07 PM


20170411 Poster ESPGHAN 2017 G...
Files produced by the author(s)


Distributed under a Creative Commons Attribution 4.0 International License


  • HAL Id : hal-01888814, version 1


Gaëtan Drouin, Daniel Catheline, Charlotte Baudry, Pascale Le Ruyet, Philippe Legrand. Impact of n-3 docosapentaenoic acid (DPA) supplementation on n-3 fatty acid composition of tissues in rats. The European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) Annual Meeting 2017, May 2017, Prague, Czech Republic. 2017, ⟨⟩. ⟨hal-01888814⟩



Record views


Files downloads